A study by Zhao, H. et al. [98] showed that ADSC-derived EVs improved metabolic balance in obese mice, enhancing insulin sensitivity by 27.8%, reducing obesity, and alleviating hepatic steatosis. This evidence concerns the gene INS and fatty liver disease.